Welcome to our dedicated page for ESAB SEC filings (Ticker: ESAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ESAB Corporation filings document the regulatory record for an industrial manufacturer of welding, cutting and joining equipment and consumables. Its Form 8-K disclosures cover operating and financial results, material-event reporting, dividend and capital-structure matters, senior unsecured notes and related subsidiary guarantees.
Proxy and governance filings describe shareholder voting matters, director and officer changes, board committee assignments, executive compensation, director independence and related governance practices. The filing record also reflects public-company reporting following ESAB's 2022 registration as a standalone issuer.
ESAB Corp reported that one of its directors received 213 deferred stock units on 12/31/2025. Each deferred stock unit represents a contingent right to receive one share of ESAB common stock. The units were issued in lieu of the director's cash retainer for Board service, so they carry a price of $0 for this grant.
The deferred stock units vest immediately, meaning the director's right to the units is not subject to additional service conditions. However, the units will be settled in ESAB common stock only after the director separates from the company, aligning the director's compensation with the long‑term value of the stock.
ESAB Corp reported a routine equity compensation move for one of its directors. On 12/31/2025, the director received 263 deferred stock units, each representing a contingent right to receive one share of ESAB common stock. These units were issued in lieu of the director's cash retainer for Board service, effectively paying board fees in stock-based form rather than cash.
The deferred stock units vest immediately, but will only be settled in ESAB common stock after the director separates from the company. This structure aligns the director’s compensation with long-term shareholder value while deferring actual share delivery until service on the Board ends.
ESAB Corp reported that one of its directors received an equity-based award tied to board service. On 12/31/2025, the director was granted 54 deferred stock units, each representing the right to receive one share of ESAB common stock. These units were issued in lieu of the director’s cash retainer for serving on the Board.
The deferred stock units vest immediately, meaning they are fully earned on the grant date, but will be settled in ESAB common stock only after the director separates from the company. This aligns the director’s compensation more closely with ESAB’s long-term share performance without involving any open-market stock purchase or sale.
ESAB Corp reported that one of its directors received equity-based compensation in the form of deferred stock units. On 12/31/2025, the director acquired 213 deferred stock units, each representing a contingent right to receive one share of ESAB common stock with a par value of $0.001 per share.
These 213 deferred stock units were issued in lieu of the director's cash retainer for Board service, meaning the director chose stock-based pay instead of cash. The units vest immediately but will be settled in ESAB common stock only after the director separates from the company, aligning part of the director's compensation with long-term shareholder interests.
ESAB Corp director Mitchell P. Rales reported a grant of 493 shares of common stock in the form of deferred stock units on December 31, 2025, at a price of $0.00 per share. These units are payable only in common stock and will be settled after he leaves the Board, at the earlier of his death or January 31 of the second calendar year following his retirement.
After this grant, he directly holds 14,453 ESAB common shares. He also reports indirect holdings, including 3,355,765 shares through a single-member LLC, 4,816-share custodial accounts for his daughter for which he disclaims beneficial ownership, and 226,421 shares held by the Mitchell P. Rales Family Trust.
ESAB Corp reported an insider stock transaction on a Form 4 by one reporting person who serves as Officer, President, Fab Tech. On 12/15/2025, the insider reported two non-derivative transactions in ESAB common stock, each labeled with transaction code "G". Each transaction involved the disposition of 320 shares of common stock at a reported price of $0 per share. Following these transactions, the filing shows directly owned common stock holdings of 14,669 shares in one line and 14,349 shares in another line.
ESAB Corp reported a routine insider equity transaction by its Controller and PAO. On 11/24/2025, 205 restricted stock units converted into the same number of shares of common stock. To cover related tax obligations, 71 shares of common stock were withheld by ESAB Corporation at a price of $107.35 per share, and no shares were sold by the insider in the market.
After these transactions, the reporting person directly owned 8,099 shares of ESAB common stock. The underlying restricted stock unit award, which vested in three equal annual installments beginning on 11/22/2023, was fully vested as of 11/22/2025, leaving no derivative securities from this grant outstanding.
ESAB Corporation announced changes to its board of directors. The Board appointed Dr. Sébastien Martin as a director, effective January 1, 2026, and increased the Board size from nine to ten members on that date. Dr. Martin, an Associate Professor of Operations at the Kellogg School of Management, will also join the Board’s Audit Committee.
His background includes research in large-scale optimization, transportation, the gig economy, public sector operations, and artificial intelligence, and he has served as an external AI advisor to ESAB since February 2025, a role he will leave before joining the Board. ESAB states that Dr. Martin will receive its standard non-employee director compensation and enter into its customary indemnification agreement, and that he qualifies as an independent director under NYSE rules.
Separately, director Patrick Allender notified the Board of his decision to retire as a director, effective at ESAB’s 2026 annual meeting of stockholders. The company notes that his retirement is not due to any disagreement regarding ESAB’s operations, policies, or practices.
ESAB Corporation announced changes to its board of directors. The Board appointed Dr. Sébastien Martin as a director, effective January 1, 2026, and increased the Board size from nine to ten members on that date. Dr. Martin, an Associate Professor of Operations at the Kellogg School of Management, will also join the Board’s Audit Committee.
His background includes research in large-scale optimization, transportation, the gig economy, public sector operations, and artificial intelligence, and he has served as an external AI advisor to ESAB since February 2025, a role he will leave before joining the Board. ESAB states that Dr. Martin will receive its standard non-employee director compensation and enter into its customary indemnification agreement, and that he qualifies as an independent director under NYSE rules.
Separately, director Patrick Allender notified the Board of his decision to retire as a director, effective at ESAB’s 2026 annual meeting of stockholders. The company notes that his retirement is not due to any disagreement regarding ESAB’s operations, policies, or practices.
ESAB Corp received a Schedule 13G/A (Amendment No. 4) from T. Rowe Price Associates, Inc. reporting beneficial ownership of 5,239,566 shares of common stock, equal to 8.6% of the class, tied to the event date September 30, 2025.
The filer reports sole voting power over 5,086,339 shares and sole dispositive power over 5,239,365 shares, with no shared voting or dispositive power. Filed in its capacity as an investment adviser, T. Rowe Price states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
ESAB Corp (ESAB) — Form 4 insider activity: A director reported routine transactions. On 07/18/2025, 6.848 shares of common stock were acquired via dividend reinvestment at $127.56 per share. On 11/11/2025, the director exercised 2,783 stock options at $33.02 and sold 2,783 shares at $114.50. Following these transactions, directly owned common shares were 8,741.91.